Correspondence 0001213900-25-007082 from Stellar V Capital Corp. (Cayman Islands) (SVCC, SVCCU) (CIK 0002033593) (SVCC)
Stellar V Capital Corp. (Cayman Islands) (SVCC, SVCCU) (CIK 0002033593)
Date: Jan. 27, 2025 · CIK: 0002033593 · Accession: 0001213900-25-007082
AI Filing Summary & Sentiment
File numbers found in text: 333-283612
Show Raw Text
CORRESP
1
filename1.htm
Giovanni Caruso
Partner
345 Park Avenue
New York, NY 10154
Direct 212.407.4866
Main 212.407.4000
Fax 212.407.4990
gcaruso@loeb.com
Via EDGAR
January 27, 2025
Stacie Gorman and Pam Howell
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re: Stellar V Capital Corp. (Cayman Islands)
Registration Statement on Form S-1
Filed December 4, 2024
File No. 333-283612
Dear Ms. Gorman and Ms. Howell:
On behalf of our client, Stellar V Capital Corp. (the “Company”),
we hereby provide a response to the oral comment issued on January 27, 2025 (the “Staff’s Comment”) regarding the Company’s
Registration Statement on Form S-1 (the “S-1”).
In the Staff’s Comment, the Staff identified certain places in
the document where we used different percentages relating to the ownership of the sponsors. The Company believes that the use of such
differing percentages to be accurate. In places where the Company refers to only the founder shares, the percentage correctly identifies
the founder shares as being 26% (with the overallotment option being exercised) and 29% (without the overallotment option being exercised).
For example, on the cover page, where we disclose the anti-dilution protection (which is based only on the founder shares), the disclosure
reads as follows:
In the case that additional Class
A ordinary shares or equity-linked securities are issued or deemed issued in connection with our initial business combination, the number
of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, approximately 26% of the total
number of Class A ordinary shares outstanding after such conversion, assuming the full exercise of the over-allotment option, or 29%,
assuming no exercise of the over-allotment option.
We make similar disclosure on page 20, where the disclosure relates
to adjustments to the founder shares in the event that the deal is resized:
If we increase or decrease the size of the offering pursuant to Rule 462(b) under the Securities Act, we will effect a share
dividend or share contribution back to capital or other appropriate mechanism, as applicable, with respect to our Class B ordinary
shares immediately prior to the consummation of the offering in such amount as to maintain the ownership of founder shares by our initial
shareholders, on an as-converted basis, at approximately 26%, assuming the full exercise of the over-allotment option, or 29%,
assuming no exercise of the over-allotment option, of our issued and outstanding ordinary shares upon the consummation of this offering.
Los Angeles New York Chicago Nashville Washington, DC San Francisco
Beijing Hong Kong www.loeb.com
For the United States offices, a
limited liability partnership including professional corporations. For Hong Kong office, a limited liability partnership.
Stacie Gorman and Pam Howell
January 27, 2025
Page 2
However, in places where the voting is relevant, the Company discusses
total ownership percentage, which includes the private placement securities. For example, the disclosure on page 42:
If we seek shareholder approval
of our initial business combination, our initial shareholders and management team have agreed to vote in favor of such initial business
combination, regardless of how our public shareholders vote.
Our initial shareholders will own
approximately 30% of our outstanding ordinary shares immediately following the completion of this offering if the over-allotment option
is not exercised and 27% if the over-allotment option is exercised (including both founder shares and private shares).
Similar disclosure appears on page 57:
Our initial shareholders, who will
collectively beneficially own approximately 30% of our ordinary shares upon the closing of this offering if the over-allotment option
is not exercised and 27% if the over-allotment option is exercised (including both founder shares and private shares, and assuming they
do not purchase any units in this offering), will participate in any vote to amend our amended and restated memorandum and articles of
association and/or trust agreement and will have the discretion to vote in any manner they choose.
The one location that this is not consistent is page 146, where it
incorrectly states that the founder shares equal 30% of the Company’s outstanding shares. The Company will revise the disclosure
as follows in the final prospectus:
If we increase or decrease the
size of this offering, we will effect a share dividend or share contribution back to capital or other appropriate mechanism, as applicable,
with respect to our Class B ordinary shares immediately prior to the consummation of the offering in such amount as to maintain the ownership
of founder shares of our initial shareholders at approximately 3029% of our issued and outstanding ordinary shares upon
the consummation of this offering.
Please call me at 212-407-4866 if you would like additional information
with respect to any of the foregoing. Thank you.
Sincerely,
/s/ Giovanni Caruso
Giovanni Caruso
Partner
cc:
Prokopios Tsirigakis